US Endocrine Review 2007 An in-depth report focusing on the latest scientific, clinical and practice management issues influencing the growth and development of the North American endocrinology market.

The US Centers for Disease Control and Prevention (CDC) reported a 50% increase in the prevalence of Diabetes Mellitus from 1997-2004, increasing by approximately 8% per annum. This corresponds with a 41% increase in the estimated number of diabetes related visits to physician’s offices and hospital outpatient departments.

Approximately 75 million Americans suffer from some type of endocrine disorder and/or related health issue, placing a substantial and rising burden on the US healthcare system. (Source: ADA) It has been estimated that diabetes and its complications alone utilize approximately 5% to 10% of the nation’s health budget. (Source: IDF) The World Health Organization (WHO) estimates that more than 1 billion people in the world are overweight and, if current trends continue, that number will reach 1.5 billion by 2015. In the USA alone, 59 million people are obese, and 40% of Americans will be obese in 5 years' time if nothing is done about this trend. Also, among people diagnosed with type 2 diabetes, 67 percent have a BMI greater than 27 (overweight) and 46 percent have a BMI greater than 30 (obese).

As a result of this, Sovereign Medical is producing US Endocrine Review to provide an in-depth analysis and overview of the endocrine market, focusing on the most relevant issues within diabetes, obesity and endocrine disorders, such as those of the pituitary, thyroid and adrenal glands as well as the range of sex-hormone-related issues.

The report will serve as a source of information for a targeted audience of medical doctors and professional caregivers involved in providing diagnosis, management and treatment regimens for all endocrine related disorders.

The publication contains specially commissioned clinical and scientific editorial from the principal thought leaders and key opinion leaders from within the US endocrinology sector, providing new clinical developments and therapies. Areas to be covered will include diabetes mellitus management, CVD and chronic kidney disease, hypertension and obesity.

Richard M Bergenstal, MD Executive Director, International Diabetes Center - Richard M Bergenstal, MD, is Executive Director of the International Diabetes Center at Park Nicollet, and is also an endocrinologist.

Larry C. Deeb, MD, President, Medicine & Science, of The American Diabetes Association (ADA). During his 25-year relationship with the ADA, Dr. Deeb has served in more than two-dozen roles, including Chair of the ADA's Council on Diabetes in Youth and Chair of the Council on Public Health. A paediatric endocrinologist, Dr. Deeb also serves as Medical Director for the Diabetes Center at Tallahassee Memorial Hospital, and is a Clinical Professor of Paediatrics at the University of Florida and Clinical Professor of Behavioural and Social Medicine at Florida State University.

Gerard Doherty, MD Secretary, International Association of Endocrine Surgeons (IAES) - Gerard Doherty, MD, is Secretary for the International Association of Endocrine Surgeons.

Debbie Jones, Regional Chair, North America, International Diabetes Federation (IDF) - Debbie Jones is currently the Director of BHB Diabetes Education Center and coordinator for its international clinical trials.

Robert Knutzen, MBA Chairman of the Board and Chief Executive Officer, Pituitary Network Association (PNA) - Robert Knutzen, MBA, is Chairman of the Board, Chief Executive Officer, and co-founder of the Pituitary Network Association (PNA).

Jeffrey I Mechanick, MD Board of Directors, American Association of Clinical Endocrinologists (AACE) - Jeffrey I Mechanick, MD, sits on the board of directors for the American Association of Clinical Endocrinologists (AACE) and is Associate Clinical Professor of Medicine in the Division of Endocrinology, Diabetes, and Bone Diseases at Mount Sinai Hospital, where he is also Director of the Metabolic Support service. Current: Director, Metabolic Support and Associate Clinical Professor of Medicine, Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai.

Malinda Peeples, immediate past president of the American Association of Diabetes Educators (AADE). As immediate past president, Peeples sits on AADE's Executive Committee and serves as chair of the Nominating Committee. She is currently a postgraduate research fellow in health sciences informatics at The Johns Hopkins University School of Medicine. Upon completion, Peeples plans to focus on integrating technology into the larger healthcare profession and using it to support the work of the clinicians.

The success of US Endocrine Review can be measured in the scope and depth of the publication's 15,000 readership, which spans medical doctors in primary and secondary care settings ranging from general practice to large general hospitals and centres of excellence across North America including:-

Endocrinologists Diabetologists Cardiologists Endocrine surgeons Nephrologists

Bariatricians including Surgeons Dietitians Selected high referring Primary care physicians Endocrinology nurses Diabetes nurses

Copies of the report will be distributed to selected members of the following professional associations in May 2007:-

American Association of Clinical Endocrinologists American Diabetes Association American Society of Bariatric Surgeons American Society of Bariatric Physicians American Society of Hypertension American Heart Association

International Diabetes Federation National Kidney Foundation National Osteoporosis Foundation Pituitary Network Association American Society of Reproductive Medicine American Thyroid Association

We are able to provide you with

• The opportunity to nominate one author to write an independent unbiased white paper for the proposed feature running to approximately 2000 words
• A Search Engine Optimised Company Profile on the official US Endocrine Review website
• A fully guaranteed precisely targeted circulation
• The reader response service in operation for 12 months after publication
• A complimentary copy of US Endocrine Review upon publication
• A strategically placed advertisement in US Endocrine Review OR additional editorial if preferred

To view an example of our current publication for primary care physicians visit www.napc-review.co.uk

• Target senior level physicians and clinicians throughout the US Endocrinology market engaged in the diagnosis, treatment and management of endocrine related disorders.
• Reach Primary Care Physicians, Diabetologists and Endocrinologists.
• Demonstrate your commitment in this therapeutic area by sharing a platform with respected thought leaders and key opinion leaders.
• Increase your "share of voice" in the competitive market for diabetes and obesity products.

 

Media Size	4 Colour		2 Colour		Black & White
	£	US$	£	US$	£	US$
Double Page	16,320	$31.000	£14,860	$28,230	£14,130	$26,850
Single Page	£9,950	$18,900	£9,150	$17,390	£8,490	$16,130
Half Page	£6,900	$13,110	£6,240	$11,850	£5,570	$10,580